Pathophygiologic heterogeneity or differences in premorbid vulnerability?
- PMID: 11124433
- DOI: 10.1016/s0197-4580(00)00185-8
Pathophygiologic heterogeneity or differences in premorbid vulnerability?
Comment on
-
Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis.Neurobiol Aging. 2000 Nov-Dec;21(6):845-61. doi: 10.1016/s0197-4580(00)00183-4. Neurobiol Aging. 2000. PMID: 11124429 Review.
Similar articles
-
Posterior cortical atrophy: a new clinical entity, or Alzheimer's disease?Arch Neurol. 1989 Aug;46(8):843-4. doi: 10.1001/archneur.1989.00520440023014. Arch Neurol. 1989. PMID: 2757523 No abstract available.
-
The focality of the global Alzheimer brain process: is the selective vulnerability of neurons a specific phenomenon of primary neuronal pathobiology?Med Hypotheses. 2004;62(5):783-7. doi: 10.1016/S0306-9877(03)00274-3. Med Hypotheses. 2004. PMID: 15082107
-
Cholinergic modulation of amyloid processing and dementia in animal models of Alzheimer's disease.Ann N Y Acad Sci. 2000;920:309-14. doi: 10.1111/j.1749-6632.2000.tb06940.x. Ann N Y Acad Sci. 2000. PMID: 11193169 Review. No abstract available.
-
Aging of the brain, entropy, and Alzheimer disease.Neurology. 2006 Oct 24;67(8):1340-52. doi: 10.1212/01.wnl.0000240127.89601.83. Neurology. 2006. PMID: 17060558 Review.
-
Looking into posterior cortical atrophy: providing insight into Alzheimer disease.Neurology. 2011 May 24;76(21):1778-9. doi: 10.1212/WNL.0b013e31821ccd4f. Epub 2011 Apr 27. Neurology. 2011. PMID: 21525423 No abstract available.
Cited by
-
Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid.PLoS One. 2017 Mar 30;12(3):e0174763. doi: 10.1371/journal.pone.0174763. eCollection 2017. PLoS One. 2017. PMID: 28358909 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical